| ABSTRACT Objective:To provide an qualitative and quantitative methods for evaluation of the effectiveness and safety of TCM injections. Methods: Taking research on Shuanghuanglian injection in treatment of acute upper respiratory tract infection as an example, to investigate the construction of traditional Chinese medicine injection risk benefit assessment system, based on multiple criteria decision analysis (MCDA) model.Results: Combining with the characteristics of TCM injections, comprehensive considerate risk and benefit of TCM injections, to build systematic risk benefit evaluation system by determining the decision environment, to build a value tree, to collect and process data, rating index, to weight assignment, sensitivity analysis and risk benefit evaluation. Conclusion:Construction of risk benefit evaluation system for TCM injection based on MCDA model, could compare comprehensive value of a variety of TCM injection in treatment of a disease and provide reference for clinical rational drug use and relevant national drug policy decisions. |
